Supercritical Fluid Extraction Patents: Leaders & White Space 2026
- Filing has cooled, not grown. activity peaked at 11 families in 2020 and the 2022 midpoint sits at just 4, a flat-to-declining trend rather than the accelerating one many assume.
- One subclass dominates the claim space. B01D separation processes appear in 163 of 195 families, far ahead of C11B fatty-oil extraction (51) and A61K medicinal preparations (42).
- No single assignee is currently active. every tracked assignee in the recent-momentum data shows zero filings in the latest year, pointing to a fragmented, long-tail ownership structure rather than a concentrated leader.
What the supercritical fluid extraction patent record actually shows
Supercritical fluid extraction (SFE) patenting sits at the intersection of separation engineering and end-use formulation. The search scope here combines core process claims — co-solvent selection, pressure-temperature conditions, extraction yield, solvent recovery — with the specific equipment and application classes B01D11 (separation), C11B1 (fatty oils and waxes) and A23L5 (foods). Across 195 patent families published between 2015 and mid-2026, the record leans heavily toward process and apparatus claims rather than novel extraction chemistries.
Filing activity has not grown steadily. It rose to a peak of 11 families in 2020, then fell back toward single digits by the 2022 midpoint, and the most recent full year shows near-zero activity — though publication lag of roughly 18 months means 2025 and 2026 filings are still understated in this count. Receiving-office data shows the United States as the largest single filing venue, with Europe, China, WIPO and India each carrying a meaningful share, indicating the technology is prosecuted internationally rather than concentrated in one jurisdiction.
Filing trend and technology composition
The two views below separate timing from subject matter: when families were filed, and which IPC subclasses carry the claim density.
A peak-and-decline filing curve
From 5 families in 2017, filings climbed to a peak of 11 in 2020, dropped to 4 by the 2022 midpoint, and trail toward zero in the partial 2026 year. Read the tail end cautiously: publication lag means the last one to two years are undercounted, but the mid-decade decline from the 2020 peak is a real signal, not an artefact of the cut-off.
Separation processes dominate, application classes trail
B01D (separation processes) appears in 163 of 195 families — the large majority of the corpus — followed by C11B (fatty oils and waxes, 51) and A61K (medicinal preparations, 42). G01N (material analysis, 36), A23L (foods, 27), B01J (catalysis-adjacent processes, 24), A61P (therapeutic activity, 13) and C07C (acyclic/carbocyclic compounds, 13) show the applied end-uses are far more fragmented than the core separation apparatus claims.
Shares are the percentage of the 195 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Supercritical Fluid Extraction with Eureka
This page is one run against one query. Ask Eureka your own question about supercritical fluid extraction and every answer comes back with the patent numbers behind it.
Try EurekaThe prior art every new filing gets checked against
Method and system for supercritical fluid extraction of metal
A method for supercritical fluid extraction of metal from a source, comprising a reactor chamber and a source with a target metal; a solvent is heated and compressed above its critical temperature and pressure, with an optional chelating agent and optional mechanical agitation, to recover a chelate comprising the target metal.Filed by The Governing Council of the University of Toronto, published 2026-06-23 as US12662390B2 — among the most recent grants in the corpus and one of the few directed at metal recovery rather than botanical, food or pharmaceutical extraction.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20040071781A1 | Composite particles and method for preparing | 161 |
| 2 | US5601707A | Apparatus and method for supercritical fluid extraction or supercritical fluid chromatography | 148 |
| 3 | US5356538A | Supercritical fluid extraction | 139 |
| 4 | US4749522A | Supercritical fluid extraction of animal derived materials | 107 |
| 5 | US5147538A | Field-portable apparatus and method for analytical supercritical fluid extraction of sorbent materials | 106 |
| 6 | US5322626A | Decoupled flow and pressure setpoints in an extraction instrument using compressible fluids | 84 |
| 7 | US5240603A | Decoupled flow and pressure setpoints in an extraction instrument using compressible fluids | 82 |
| 8 | US5599381A | Separation of solutes in gaseous solvents | 80 |
| 9 | US5866004A | Automated supercritical fluid extraction method and apparatus | 75 |
| 10 | US5087360A | Field-portable apparatus and method for analytical supercritical fluid extraction of sorbent materials | 64 |
Citation counts favour older filings simply by virtue of longer exposure; treat them as markers of influence on the field's vocabulary, not of current relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Four patterns in the data matter more than any single ranking: where claim density sits, what is cited most, how offices split, and how thin recent-year momentum has become.
Separation apparatus claims are the crowded ground
With B01D present in 163 of 195 families, new apparatus-level claims on the core extraction vessel, pressure control or solvent-recovery loop face the densest prior art in the corpus. Differentiation is more likely to succeed in the application-specific classes that trail behind, such as A23L or A61P, where filing counts are a third or less of B01D's.
A handful of 1980s-2000s patents still frame the field's language
The most-cited records date back to the 1990s and early 2000s, including foundational apparatus and method patents for supercritical fluid extraction and chromatography. Their citation weight reflects decades of exposure, not current commercial relevance, but new filings are still drafted around the terms these documents established.
Prosecution is US-led but genuinely international
The United States received the largest share of filings, with Europe and China each carrying roughly half that volume, and WIPO PCT and India filings indicating deliberate multi-jurisdiction strategies rather than single-market protection.
No assignee is currently pressing forward
Every organisation in the recent-momentum data shows zero filings in the latest tracked year. Combined with the flat-to-declining filing trend since 2020, this suggests the field has moved from active buildup to a maintenance phase for existing portfolios.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to supercritical fluid extraction, with the prior art for and against each one.
A fragmented ownership structure, not a two-horse race
Co-assignee pairings and momentum data both point the same direction: ownership of this claim space is distributed across food, chemical and academic filers rather than held by one or two dominant firms.
PepsiCo-linked filings cluster with named inventors
The strongest co-assignee pairings in the dataset link a PepsiCo entity with individual named inventors across multiple filings, consistent with an internal R&D program filing jointly rather than through external partners.
Legacy chemical filers hold portfolio but are not adding to it
Dow Chemical appears among the tracked assignees but shows no filings in the latest year, matching the broader pattern of established players holding existing claims rather than expanding them.
Universities and small firms make up the long tail
Beyond the handful of named assignees with multiple filings, the corpus includes numerous single-institution and single-inventor filings, including recent university-originated grants, indicating a long tail of narrowly-scoped entrants rather than a concentrated few.
| Assignee | Recent year | YoY |
|---|---|---|
| Firmenich | 0 | — |
| WHITLOCK DAVID R | 0 | — |
| PepsiCo, Inc. (USA) | 0 | — |
| Universiti Putra Malaysia | 0 | — |
| Dow Chemical Company | 0 | — |
| Hewlett-Packard Company | 0 | — |
| Anhui Yingshang Sanjin Grain and Oil Co., Ltd. | 0 | — |
| SUPREX CORP | 0 | — |
Where to take this analysis
The dataset points to specific next steps depending on whether the goal is freedom-to-operate, portfolio building, or scouting.
Run a freedom-to-operate check on B01D claims
Given 163 of 195 families sit in B01D, any new apparatus or process claim should be checked against this subclass specifically before drafting, not just against the corpus as a whole.
Explore in EurekaMap the under-claimed application branches
A23L, A61P and C07C each carry a fraction of B01D's filing density, suggesting room for application-specific claims in food, therapeutic and compound-recovery uses.
Explore in EurekaTrack dormant assignees for licensing or acquisition signals
Zero recent-year activity across tracked assignees may indicate portfolios available for licensing rather than active enforcement; a targeted assignee review would confirm this.
Explore in EurekaCommon questions about supercritical fluid extraction patents
This dataset tracks 195 patent families published between 2015 and mid-2026 that combine supercritical fluid or supercritical CO2 extraction terminology with claims around co-solvent use, selectivity, pressure-temperature conditions, extraction yield or solvent recovery, filtered to the B01D11, C11B1 and A23L5 IPC classes. The true global count for supercritical fluid extraction broadly is larger, since this scope deliberately excludes filings outside those process and equipment classes. Family counts are the fairer unit to cite than raw document counts because they remove duplicate continuation and multi-jurisdiction filings of the same invention.
The ranking in this corpus does not show one dominant assignee; instead it shows a long tail of academic institutions, mid-size chemical and food companies, and individual inventors, several with only one or two filings each. Named organisations that do appear with multiple filings include consumer goods and chemical companies, but every one of them shows zero filings in the most recent tracked year. That pattern indicates a field where portfolios were built earlier in the decade and are now being held rather than actively expanded.
Slowing, based on the trend in this dataset. Filings rose from 5 in 2017 to a peak of 11 in 2020, then fell to 4 by the 2022 midpoint and continued declining toward the most recent partial year. Because publication typically lags filing by around 18 months, the final one to two years in any such count will always look thinner than they eventually turn out to be, but the multi-year decline from the 2020 peak predates that lag effect and looks like a genuine slowdown.
US12662390B2, assigned to the Governing Council of the University of Toronto and published mid-2026, claims a method for supercritical fluid extraction of metal from a source using a reactor chamber, an optional chelating agent, a solvent heated and compressed above its critical point, and recovery of a metal-bearing chelate. It is notable in this corpus for targeting metal recovery specifically, a use case that appears in almost none of the other 195 families, which cluster around botanical, food and pharmaceutical extraction. Anyone designing a supercritical CO2 or supercritical fluid process for metal or mineral recovery using a chelating agent should review this claim set closely, since it sits in largely unoccupied claim space rather than a crowded one.
The clearest gaps sit outside the dominant B01D separation-apparatus core, in application classes with far lower filing density: A61P therapeutic activity and C07C acyclic and carbocyclic compounds each show only 13 families against B01D's 163. Metal and mineral recovery, as in the University of Toronto filing, is another thinly-populated branch. Continuous-flow processing for food-grade output and fine-tuned co-solvent selectivity for polar actives also show fewer filings relative to the core apparatus claims, making them reasonable areas to scout before assuming the space is occupied.
Research Supercritical Fluid Extraction in depth with Eureka
Go past this page: query the whole supercritical fluid extraction corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.